If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@CUAnschutz.edu
COMIRB # | Title (Please click on the title to see approved advertisement) | Principal Investigator | Eligibility and Information | Advertisement |
---|---|---|---|---|
12-0968 | Rocky Mountain Multiple Sclerosis Center (RMMSC) Biorepository for the Study of Neuroimmunological Disorders | Alvarez, Enrique, MD | Clinical Trials | N/A |
18-1633 | Determining the Effectiveness of Early Intensive Versus Escalation Approaches for the Treatment of Relapsing-Remitting Multiple Sclerosis (DELIVER-MS) | Alvarez, Enrique, MD | Clinical Trials | N/A |
15-2388 | Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (DISCO-MS) | Corboy, John R., MD | Clinical Trials | See Advertisement |
17-1884 | Risk Factors in Early Multiple Sclerosis (RISE-MS) | Corboy, John R., MD | Clinical Trials | See Advertisement |
08-0613 | The role of TH40 cell in Multiple Sclerosis and Type 1 Diabetes | Corboy, John R., MD | N/A | N/A |
09-0952 | Rocky Mountain MS Center Tissue Bank | Corboy, John R., MD | Clinical Trials | N/A |
18-0179 | Comparative Effectiveness of an Exercise Intervention Delivered via Telerehabilitation and Conventional Mode of Delivery | Jeffrey Hebert, PT, PhD | Clinical Trials | See Advertisement |
16-0156 | Natalizumab for Prevention of Post-Partum Relapses in Patients with Multiple Sclerosis | Schreiner, Teri L., MD, MPH | Clinical Trials | N/A |
12-1102 | Pediatric Multiple Sclerosis and other Demyelinating Diseases Database (PeMSDD Database) | Schreiner, Teri L., MD, MPH | N/A | N/A |
19-1040 | A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Ocrelizumab Administration in Patients with Multiple Sclerosis | Piquet, Amanda, MD | Clinical Trials | N/A |
19-2525 | Lipoic acid for Treatment of Progressive Multiple Sclerosis | Gross, Robert, MD | Clinical Trials | N/A |